{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:46:07Z","timestamp":1777329967799,"version":"3.51.4"},"reference-count":16,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Over the past five years, the\n                    <jats:italic>MYCBP2<\/jats:italic>\n                    has emerged as a potential candidate gene associated with neurodevelopmental disorders (NDDs). In 2023, a newly characterized condition, termed\n                    <jats:italic>MYCBP2<\/jats:italic>\n                    -related developmental delay with corpus callosum defects (MDCD), has been reported in eight individuals presenting corpus callosum abnormalities, developmental delay, intellectual disability, epilepsy and autistic features. To date, all reported cases have been associated with distinct\n                    <jats:italic>de novo<\/jats:italic>\n                    variants. Here, we describe the first family with three affected members carrying a novel pathogenic\n                    <jats:italic>MYCBP2<\/jats:italic>\n                    variant. A mother and her two sons were referred to our laboratory for genetic testing. The phenotypic characteristics of our three patients included intellectual disability, speech impairment, facial dysmorphism, microcephaly and seizures (presented only in the mother). We performed WES on the three affected family members using Twist Human Core+RefSeq+Mitochondrial Panel on Illumina Nova Seq 6000. We have identified a novel loss of function variant in\n                    <jats:italic>MYCBP2<\/jats:italic>\n                    [NM_015057.5 c.7311del, p.(Leu2438Trpfs*3)] in heterozygous state in the mother and her two sons. The variant causes a frameshift, leading to NMD and C-terminal truncation, eliminating key domains (RING and TC) essential for ubiquitin ligase activity and interactions with other cellular components, particularly in processes related to synaptic regulation. Here, we present the clinical manifestation of\n                    <jats:italic>MYCBP2<\/jats:italic>\n                    -related developmental delay in three patients of a same family. Our study further supports the critical role of\n                    <jats:italic>MYCBP2<\/jats:italic>\n                    in the pathogenesis of NDDs and contributes to the phenotype of a recently recognized MDCD syndrome.\n                  <\/jats:p>","DOI":"10.2478\/bjmg-2025-0007","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:00:04Z","timestamp":1759986004000},"source":"Crossref","is-referenced-by-count":0,"title":["First Report of a Familiar\n                    <i>MYCBP2<\/i>\n                    Pathogenic Variant: Expanding the Knowledge of Neurodevelopmental Disorders"],"prefix":"10.2478","volume":"28","author":[{"given":"I","family":"Maleva Kostovska","sequence":"first","affiliation":[{"name":"Research Center for Genetic Engineering and Biotechnology \u201cGeorgi D. Efremov\u201d, Macedonian Academy of Science and Arts , Skopje , North Macedonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Noveski","sequence":"additional","affiliation":[{"name":"Research Center for Genetic Engineering and Biotechnology \u201cGeorgi D. Efremov\u201d, Macedonian Academy of Science and Arts , Skopje , North Macedonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Sukarova-Angelovska","sequence":"additional","affiliation":[{"name":"University Pediatric Clinic, Medical Faculty , Skopje , Republic of North Macedonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Plaseska-Karanfilska","sequence":"additional","affiliation":[{"name":"Research Center for Genetic Engineering and Biotechnology \u201cGeorgi D. Efremov\u201d, Macedonian Academy of Science and Arts , Skopje , North Macedonia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"2026042718411377131_j_bjmg-2025-0007_ref_001","doi-asserted-by":"crossref","unstructured":"Grill B, Murphey RK, Borgen MA. The PHR proteins: intracellular signaling hubs in neuronal development and axon degeneration. Neural Develop. 2016;11(1):1\u201318.","DOI":"10.1186\/s13064-016-0063-0"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_002","doi-asserted-by":"crossref","unstructured":"Opperman KJ, Grill B. RPM-1 is localized to distinct subcellular compartments and regulates axon length in GABAergic motor neurons. Neural Develop. 2014;9:1\u201315.","DOI":"10.1186\/1749-8104-9-10"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_003","doi-asserted-by":"crossref","unstructured":"Lewcock JW, Genoud N, Lettieri K, Pfaff SL. The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron. 2007;56(4):604\u2013620.","DOI":"10.1016\/j.neuron.2007.09.009"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_004","doi-asserted-by":"crossref","unstructured":"D'Souza J, Hendricks M, Le Guyader S, Subburaju S, Grunewald B, et al. Formation of the retinotectal projection requires Esrom, an ortholog of PAM (protein associated with Myc). 2005.","DOI":"10.1242\/dev.01578"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_005","doi-asserted-by":"crossref","unstructured":"Borgen M, Rowland K, Boerner J, Lloyd B, Khan A, Murphey R. Axon termination, pruning, and synaptogenesis in the giant fiber system of Drosophila melanogaster is promoted by highwire. Genetics. 2017;205(3):1229\u20131245.","DOI":"10.1534\/genetics.116.197343"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_006","doi-asserted-by":"crossref","unstructured":"Kosmicki JA, Samocha KE, Howrigan DP, Sanders SJ, Slowikowski K, Lek M, et al. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet. 2017;49(4):504\u2013510.","DOI":"10.1038\/ng.3789"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_007","doi-asserted-by":"crossref","unstructured":"Neale BM, Kou Y, Liu L, Ma'Ayan A, Samocha K, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485(7397):242\u2013245.","DOI":"10.1038\/nature11011"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_008","doi-asserted-by":"crossref","unstructured":"Bertoli-Avella AM, Kandaswamy KK, Khan S, Ordonez-Herrera N, Tripolszki K, et al. Combining exome\/genome sequencing with data repository analysis reveals novel gene\u2013disease associations for a wide range of genetic disorders. Genet Med. 2021;23(8):1551\u20131568.","DOI":"10.1038\/s41436-021-01159-0"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_009","doi-asserted-by":"crossref","unstructured":"AlAbdi L., Desbois M., Rusnac DV, Sulaiman RA, Rosenfeld JA, Lalani S, Murdock DR, et al. Loss-of-function variants in MYCBP2 cause neurobehavioural phenotypes and corpus callosum defects. Brain. 2023;146(4):1373\u20131387.","DOI":"10.1093\/brain\/awac364"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_010","doi-asserted-by":"crossref","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625(7993):92\u2013100.","DOI":"10.1038\/s41586-023-06045-0"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_011","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405\u2013424. doi:10.1038\/gim.2015.30","DOI":"10.1038\/gim.2015.30"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_012","doi-asserted-by":"crossref","unstructured":"Xiang J, Peng J, Baxter S, Peng Z. AutoPVS1: An automatic classification tool for PVS1 interpretation of null variants. Hum Mutat. 2020;41(9):1488\u20131498.","DOI":"10.1002\/humu.24051"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_013","doi-asserted-by":"crossref","unstructured":"McRae et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542(7642):433\u2013438.","DOI":"10.1038\/nature21062"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_014","doi-asserted-by":"crossref","unstructured":"Lin Y, Afshar S, Rajadhyaksha AM, Potash JB, Han S. A machine learning approach to predicting autism risk genes: Validation of known genes and discovery of new candidates. Front Genet. 2020;11:500064.","DOI":"10.3389\/fgene.2020.500064"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_015","doi-asserted-by":"crossref","unstructured":"Bertoli-Avella AM, Kandaswamy KK, Khan S, Ordonez-Herrera N, Tripolszki K, Beetz C, et al. Combining exome\/genome sequencing with data repository analysis reveals novel gene\u2013disease associations for a wide range of genetic disorders. Genet Med. 2021;23(8):1551\u20131568.","DOI":"10.1038\/s41436-021-01159-0"},{"key":"2026042718411377131_j_bjmg-2025-0007_ref_016","doi-asserted-by":"crossref","unstructured":"Virdee S. An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration. Neural Regen Res. 2022;17(11):2347.","DOI":"10.4103\/1673-5374.338992"}],"container-title":["Balkan Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/bjmg-2025-0007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:14:31Z","timestamp":1777328071000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/bjmg-2025-0007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,8]]},"published-print":{"date-parts":[[2025,6,1]]}},"alternative-id":["10.2478\/bjmg-2025-0007"],"URL":"https:\/\/doi.org\/10.2478\/bjmg-2025-0007","relation":{},"ISSN":["2199-5761"],"issn-type":[{"value":"2199-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"20250007"}}